SRT-2104

DB12186InvestigationalSmall molecule

SRT2104 has been investigated for the basic science and treatment of Sepsis, PSORIASIS, Atrophy, Muscular, and Diabetes Mellitus, Type 2.

Mechanism: Pharmacologically active on NAD-dependent protein deacetylase sirtuin-1
Curator reviewed
Formula / weight: C₂₆H₂₄N₆O₂S₂ · 516.64 g/mol (avg)
Code names: SRT2104

Resolves to

Compound

Structure

InChIKeyLAMQVIQMVKWXOC-UHFFFAOYSA-NSMILESCC1=C(SC(=N1)C1=CC=CN=C1)C(=O)NC1=CC=CC=C1C1=CN2C(CN3CCOCC3)=CSC2=N1

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

9Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with SRT-2104, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.